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Abstract
Purpose Ventilation/perfusion tomography (V/PSPECT),
with new interpretation criteria and newer tracers for venti-
lation imaging, has markedly improved the diagnostic yield
in acute pulmonary embolism (PE). Here, we evaluated the
diagnostic performance of perfusion SPECT (PSPECT) with-
out ventilation imaging.
Methods We studied 152 patients with clinically suspected
PE who had been examined with both V/PSPECT and
multidetector computed tomographic angiography (MD-
CTA). The diagnosis or exclusion of PE was decided by
the referring clinician based on both the V/PSPECT and/or
MD-CTA findings in combination with the clinical findings.
PSPECT images were retrospectively examined by a physi-
cian with experience in the interpretation of planar perfusion
scans who was blinded to clinical, V/PSPECT and MD-CTA
data. PSPECT images were interpreted without the aid of
chest radiography. All the patients who were deemed to
have PE were given anticoagulant therapy.
Results Of the 152 patients, 59 (39 %) received a final
diagnosis of PE, and 19 (32 %) had associated cardiopul-
monary diseases such as pneumonia, COPD, or left heart
failure. PSPECT correctly identified 53 (90 %) of the 59
patients with PE. The specificity was 88 of 93 (95 %).
None of the PSPECT images was rated nondiagnostic.
PSPECT yielded an overall diagnostic accuracy of 93 %
(95 % confidence interval, CI, 87–96 %). At the observed
PE prevalence of 39 %, the positive and negative predictive
values of PSPECT were 91 % (95 % CI, 80–97 %) and 94 %
(95 % CI, 86–97 %), respectively.
Conclusion In managing critically ill patients, PSPECT might
be a valid alternative to V/PSPECT or MD-CTA since it was
able to identify most patients with PE with a low false-
positive rate and no inconclusive results.
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Introduction
Pulmonary embolism (PE) is a common but still
underdiagnosed condition. In a survey of the relevant liter-
ature from 1945 through 2002, PE was unsuspected or
undiagnosed ante-mortem in 84 % of patients who had PE
discovered at autopsy [1]. Remarkably, 78 % of patients
with large or fatal PE were never suspected of having the
disease during life [1]. Raising the suspicion of PE is the
fundamental step in the diagnostic work-up because it
allows selection of patients in whom objective tests are
mandatory to confirm or exclude the diagnosis [2, 3].
Multidetector computed tomographic angiography (MD-
CTA) is used by many as the first-line imaging tech-
nique for suspected PE. Contrast-enhanced CT has
changed the practice of medicine, particularly in emer-
gency departments [4], but it has a number of contrain-
dications, and is associated with a substantial radiation
burden to the patient [5].
Ventilation/perfusion (V/P) scintigraphy has long been
used in the evaluation of suspected PE. In the first
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Prospective Investigation of Pulmonary Embolism
Diagnosis (PIOPED I) study, only a minority of patients
with established PE had a high probability on the V/P scan
(segmental or lobar perfusion defect with normal ventila-
tion). In most patients, V/P yielded inconclusive results [6].
In recent years, the advent of single photon emission CT
(SPECT), new interpretation criteria, and the use of newer
tracers for ventilation imaging have markedly improved the
diagnostic accuracy of V/P scintigraphy in the diagnosis of
acute PE. In a recent, broad investigation, a sensitivity of
99 %, and a specificity of 98 % were found [7]. In a
prospective study published in 1996, planar perfusion scin-
tigraphy (without ventilation imaging) yielded a sensitivity
of 86 % and a specificity of 93 % in comparison with
pulmonary angiography as the reference diagnostic standard
[8]. Similar results were obtained from a retrospective ex-
amination of the planar perfusion scans from the PIOPED II
study [9].
In the present study, we evaluated the diagnostic perfor-
mance of PSPECT in a sample of 152 patients suspected of
having PE.
If PSPECT alone had a sensitivity and specificity similar
to that of V/PSPECT, it could be a valuable alternative in
managing critically ill patients and those who might not
be able to cooperate due to multiple trauma or neuro-
logical disorders.
Patients and methods
Sample
Over a 1.5-year period, 152 patients with clinically suspected
PEwere examinedwith both V/PSPECTandMD-CTA at Skåne
University Hospital, Lund, Sweden. The clinical suspicion of
PE was based on the presence of relevant symptoms
(unexplained dyspnoea, chest pain, fainting or syncope,
haemoptysis, palpitations), and the presence of arterial
hypoxaemia and/or signs of right ventricular strain on electro-
cardiography or echocardiography. No formal assessment of
the pretest (clinical) probability of PE was made by the at-
tending physicians.
V/PSPECT
V/PSPECT was performed with a large field-of-view dual-
head gamma camera with low-energy all-purpose collima-
tors and a 64×64 matrix used with 128 projections over
360°. While in the supine position, patients inhaled aerosol-
ized 99mTc-pertechnetate (Technegas; Cyclomedica, Lucas
Heights, Australia) or 99mTc-DTPA (SmartVent; Diagnostic
Imaging, Welford, UK) until about 30 MBq had reached the
lung. The acquisition of each projection took 10 s.
Immediately afterwards, and without moving the patient,
120 MBq 99mTc-MAA, (TechneScan LyoMAA; Mallinckrodt
Medical) was given intravenously for the perfusion study. This
was followed by perfusion tomography in which the
acquisition of each projection took 5 s. The patient
carefully maintained his/her supine position during the
ventilation/perfusion acquisition. Immobilization lasting
20 min was usually well tolerated even by critically ill
patients. Iterative reconstruction was performed using
ordered-subsets expectation maximization with eight subsets
and two iterations. Ventilation background was subtracted
from the perfusion tomogram, and a normalized V/P
image set (V/Pquotient) was calculated. The methodology
is described in full elsewhere [7, 10–12].
V/PSPECT diagnostic criteria
In accordance with the European guidelines:
1. No PE: normal perfusion scan or a maximum of one
mismatch point (one subsegment).
2. PE: one segmental or two subsegmental mismatches, at
least two points.
3. Disorders other than PE: perfusion and ventilation de-
fects showing match or reversed mismatch. The reader
reports if the pattern observed is suggestive of other
lung diseases such as pneumonia, left heart failure,
chronic obstructive pulmonary disease (COPD) or lung
cancer. For the sake of this study, these alternative
diagnoses are categorized as ‘No PE’.
4. Nondiagnostic for PE: complex V/P defects which make
the judgement of mismatch impossible or nontypical V/P
defects.
In the present study, the V/PSPECT scans were interpreted
by one of ten doctors of the Department of Clinical
Physiology, Lund, as part of their daily clinical activities.
For practical purposes, the extent of PE, as assessed by
V/PSPECT, was categorized as small (occlusion less than
20 % of the pulmonary vascular bed), moderate (21–50 %),
or large (greater than 50 %) [13].
PSPECT diagnostic criteria
1. No PE: no perfusion defects.
2. PE: single or multiple wedge-shaped perfusion defects,
according to the European Association of Nuclear
Medicine Guideline criteria, first used in the Prospective
Investigative Study on Acute Pulmonary Embolism
Diagnosis (PISA-PED) study [8].
3. Disorders other than PE: perfusion defects other than
wedge-shaped [8]. They are categorized here as ‘No PE’.
PSPECT images were examined retrospectively by one of
the authors (M.M., of the University of Florence, Italy) with
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long experience in the interpretation of planar perfusion
scans. The reviewer was blinded to clinical, VSPECT, and
MD-CTA data. The PSPECT images were interpreted without
the aid of chest radiography.
Multidetector CT angiography
Patients were examined with a 16-multidetector CT
scanner during a deep-inspiration breath-hold for 10 s.
Technical conditions were: 120 kVp, 190 mAs per slice,
16×1.5 mm collimator, 0.5 s rotation time, and 0.938
pitch. The images were acquired in the caudocranial
direction in a 512×512 matrix. Contrast medium
(70 ml; Omnipaque; General Electric) was administered
intravenously at 4 ml/s. Angiographic criteria for the
diagnosis of PE included the identification of an embo-
lus obstructing a vessel, or the outline of an embolus
within a vessel.
Final diagnosis
The final diagnosis (PE present or absent) was
established by the physician responsible for the patient’s
care. It was based on the clinical findings in combina-
tion with the results of both V/PSPECT and MD-CTA, or
compression ultrasonography showing deep vein throm-
bosis in the patients in whom V/PSPECT or MD-CTA
yielded inconclusive results. All the patients who were
deemed to have PE received anticoagulant therapy.
Anticoagulation was withheld or withdrawn in those
who were deemed not to have PE. All the patients were
followed for up to 3 months. Outcome measures includ-
ed hospital readmissions for any cause, recurrent epi-
sodes of PE, and death.
Statistical analysis
Sensitivity is defined as the proportion of tests categorized
as positive for PE among the patients who were deemed to
have PE by the final clinical judgement. Specificity is the
proportion of tests categorized as negative for PE among the
patients who were deemed not to have PE. Accuracy is the
sum of true positive and true negative results divided by the
total number of patients. Positive predictive value is the
proportion of patients with PE among those who had a
positive test. Negative predictive value is the proportion of
patients without PE among those who had a negative test.
According to the binomial distribution, 95 % confidence
intervals (CI) were calculated with continuity correction.
The agreement between PSPECT and V/PSPECT, or MD-CTA
ratings was tested using the kappa statistic. The statistical
analysis was performed with Stata, version 10 (StataCorp,
College Station, TX).
Results
The 152 patients included had a median age of 61 years
(interquartile range 40–73 years), 76 (44 %) were men, 97
(64 %) were outpatients at the time of study entry, and 27
(18 %) had active cancer. The diagnosis or exclusion of PE
was based on the congruent results of MD-CTA and V/PSPECT
in 88 patients (58 %), MD-CTA in 9 patients (6 %), V/PSPECT
in 53 patients (35 %), and compression ultrasonography in 2
patients (1 %). A final diagnosis of PE was established in 59
(39 %) of the 152 patients, by both MD-CTA and V/PSPECT in
28 patients, by V/PSPECT in 29 patients, and by compression
ultrasonography showing deep vein thrombosis in 2 patients
with inconclusive MD-CTA or V/PSPECT results. Of the 59
patients with PE, 19 (32 %) had associated cardiopulmonary
disorders (pneumonia in 10, left heart failure in 5 and COPD
in 2). One patient had PE, lung cancer and COPD, and one PE
and lung cancer. The diagnosis of PE was excluded in 93
patients, by both MD-CTA and V/PSPECT in 61 patients, by
MD-CTA in 8 patients, and by V/PSPECT in 24 patients. Of
these 93 patients, 13 had pneumonia, 10 acute left heart
failure, 10 exacerbation of COPD, and 2 lung cancer.
None of the patients, who were deemed not to have PE,
developed symptomatic episodes of PE during a 3-month
follow-up. None of the patients with established PE had
recurrent embolic events during follow-up, and none died
from PE. As shown in Table 1, PSPECT correctly identified
53 (90 %) of the 59 patients with PE. The specificity was 88
of 93 (95 %). None of the PSPECT images was rated
nondiagnostic. PSPECT yielded an overall diagnostic accura-
cy of 93 % (95 % CI 87–96 %). At the observed PE
prevalence of 39 %, the positive and negative predictive
values for PSPECT were 91 % (95 % CI 80–97 %) and
94 % (95 % CI 86–97 %), respectively. Figure 1 shows
characteristic PSPECT images in a patient with multiple per-
fusion defects caused by PE. Figure 2 shows a patient with
pneumonia who was misinterpreted as having PE on PSPECT.
Figure 3 shows images in a patient with perfusion defects
that were interpreted as true-negative for PE.
Table 1 Sensitivity and specificity of PSPECT for PE
Number (%) of patients 95 % CI
PE present
True-positive 53/59 (90) 80–96
False-negative 6/59 (10) 4–20
Nondiagnostic 0/59 (0) 0–5
PE absent
True-negative 88/93 (95) 89–98
False-positive 5/93 (5) 2–11
Nondiagnostic 0/93 (0) 0–3
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The agreement between PSPECT ratings and MD-CTA
was excellent (observed agreement 98 %, kappa 0.95),
and it was very good with V/PSPECT (observed agreement
91 %, kappa 0.83).
Discussion
PE remains a challenging diagnostic problem because clini-
cians still fail to raise suspicion of the disease promptly. In
recent years, MD-CTA has become the imaging modality of
choice for PE in most hospitals worldwide. Mamlouk et al.
evaluated retrospectively the medical records of 2003 consec-
utive patients who underwent MD-CTA for possible PE over a
1.5-year period [14]. The overall prevalence of PE was only
9.8 % (197/2003), and in particular, the occurrence of a
positive angiogram in the patients with no risk factors for PE
was as low as 1 % (5/520) [14]. It seems, therefore, that MD-
CTA is increasingly used as a screening method rather than as
a means to confirm or exclude clinically suspected PE. This
may contribute to inflating the costs of diagnostic procedures
for PE, and to expose the patients to an undue amount of
radiation. Radiation exposure is of concern, especially in
women of child-bearing age. In fact, using a contemporary
64-detector CTA protocol for PE, the absorbed dose to the
female breast is in the range 3.5–4.2 cGy [15], which is 30
times greater than that absorbed during V/P scintigraphy
(0.08 cGy) [10]. In addition, MD-CTA is contraindicated in
patients with renal failure, severe heart failure and allergy to
contrast agents, and during pregnancy [10, 11]. Alternative
imaging modalities will therefore continue to be needed.
In the present study, using the EANM interpretation
criteria, PSPECT was accurate in diagnosing or excluding PE
with a sensitivity of 90 %, and specificity of 95 %. In a recent
investigation, Gutte et al., interpreted PSPECT images in con-
junction with low-dose CT using a hybrid gamma camera [11,
16]. They found a sensitivity of 93 % but a specificity of only
51 %. Such a low specificity is probably due to the different
criteria used for interpreting perfusion defects. In a recent
multicentre study using planar imaging and MD-CTA, the
sensitivity and specificity for planar lung scintigraphy for the
detection of PE were 86 % and 81 %, respectively, when
PISA-PED interpretation criteria were applied [17]. Sostman
et al. found a sensitivity of planar perfusion imaging of 81 %
(slightly lower than found be He at al.), but the specificity was
97 % [9, 17]. Recently, Morris et al. reported the preliminary
clinical application of a new positive tracer for PE consisting
of 99mTc-labelled antibodies against the Fab′ fragment of the
D-dimer moiety (99mTc-DI-80B3) [18]. They studied 52 pa-
tients with moderate or high clinical probability, using MD-
Fig. 1 PSPECT in a patient with
PE: multiple well-delineated
wedge-shaped perfusion defects
(arrows) on frontal and sagittal
slices
Ventilation
Perfusion
Sagittal slices  right lung
Fig. 2 False-positive PSPECT in a patient with pneumonia: single wedge-
shaped perfusion defects (arrows) on sagittal slices. Corresponding ven-
tilation images showed a defect in the same area. Laboratory findings and
chest radiography were also positive, and the patient was treated for
pneumonia
Perfusion
Sagittal slices  right lung
Fig. 3 True-negative PSPECT in a patient with left heart failure. Perfusion
is redistributed to the anterior parts of the lung (nonsegmental perfusion
defect)
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CTA as the reference diagnostic standard. 99mTc-DI-80B3
uptake in the lungs was assessed by thoracic SPECT at 2.5 h
after intravenous administration of the labelled antibody. Of
52 the patients, 42 (81 %) had both evaluable MD-CTA and a
99mTc-DI-80B3 scan. The latter yielded a sensitivity for PE of
76% (95%CI 53–92%) and a specificity of 90.5% (95%CI,
70–99 %) [18]. The sensitivity is far lower than ours with
PSPECT.
The high diagnostic accuracy of PSPECT is of impor-
tance because this technique could be advantageously
used in clinical practice, especially in patients in whom
ventilation imaging cannot be performed such as those
who are clinically unstable or unconscious, or women
during the first trimester of pregnancy. However, it
should be born in mind that small emboli in the lingula
and the right middle lobe might be missed by PSPECT
due to the shape of these segments. Furthermore, false-
positive PSPECT may occur in some patients with pneumonia
(Fig. 2) or COPD.
Our study had some limitations. First, in 35 % of the
patients, although MD-CTA results were available, the
V/PSPECT report was used by the clinicians as referent to
diagnose or exclude PE. In some of these patients this was
dependent on inconclusive MD-CTA findings. However, it
is unlikely that an incorporation bias occurred because the
physician in charge of examining the PSPECT images was
blinded to the reference diagnostic technique and all other
clinical data. Second, the study sample was relatively small.
Third, PSPECT images were interpreted by one reader only.
Further studies are needed to assess interobserver agreement
in interpreting PSPECT images, and to establish whether the
examination of chest radiographs could improve the diag-
nostic performance of PSPECT [9]. Fourth, the diagnosis or
exclusion of PE was based on the results of two imaging
modalities (MD-CTA and V/PSPECT) that feature different
characteristics.
In the past, selective or superselective pulmonary angiog-
raphy has been used as the reference diagnostic standard for
PE [3, 6]. Conventional pulmonary angiography is now sel-
dom used in clinical practice, its application being restricted to
highly specialized centres. In the PIOPED II, a multicentre
study aimed at assessing the accuracy of MD-CTA, a com-
posite reference standard was used to diagnose or rule out PE
[19]. This included the evaluation of one or more of the
following tests: digital subtraction pulmonary angiography
(DSA), V/P lung scintigraphy, and venous compression ultra-
sonography. DSA was performed in only 225 (27 %) of the
824 patients enrolled in the study.
In summary, the present results suggest that PSPECT might
be a valid alternative to V/PSPECT in patients in whom
ventilation imaging cannot be performed, since it allows
identification of most patients with PE with a low false-
positive rate and no inconclusive results.
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